JPH0925214A - Skin preparation for external use - Google Patents

Abstract

PROBLEM TO BE SOLVED: To obtain a skin preparation for external use having melanin- suppressing action and protease-inhibiting action by using an extract of a specific plant growing at a dry grass-land, a pastureland, etc., in Andes, etc. SOLUTION: This preparation contains an extract of Yawar Piri-Piri. The extract is obtained by dipping leaves, stalks, fruits, etc. and whole herbs of the Yawar Piri-Piri in an extracting solvent or heat-refluxing together with the solvent, filtering and condensing. A mixing amount of the extract of the Yawar Piri-Piri is 0.05-20.0wt.% as a dry material based on the weight of the whole preparation for external use. The skin preparation for external use is especially useful as a whitening agent and a protease inhibitor. The skin preparation for external use is effective for preventing and improving of chromatosis, spot, freckle, chloasma, etc., after sunburn and also has a serine protease- inhibiting activity utilizable for improving of cutaneous disease wherein activity variation of protease is recognized in a patient part, such as contact-type dermatitis, psoriasis, vulgaris pemphigus, congenital bullous pemphigoid, other skin roughness, chapped skin, etc., or ulitizable as a hemostatic agent.

Description

Detailed Description of the Invention

[0001]

BACKGROUND OF THE INVENTION The present invention relates to a yawa pi-pi-pi (Y
awar Piri-Piri, scientific name: Eleucerine pli
The skin external preparation containing the extract of (cata), more specifically, it suppresses the production of melanin, is effective in the prevention and amelioration of pigmentation, spots, freckles, chloasma, etc. after sunburn, and at the same time the protease in the affected area. Topical dermatitis, psoriasis, pemphigus vulgaris, congenital chicken pox, other skin diseases such as rough skin, rough skin, etc., which have a change in the activity of serine protease that can be used as a hemostatic agent Regarding agents.

[0002]

BACKGROUND OF THE INVENTION Although there are some unclear points about the mechanism of the generation of skin spots and the like, it is generally caused by hormonal abnormalities and irritation of ultraviolet rays from sunlight. It is believed that melanin pigment is formed, which is abnormally deposited in the skin. This melanin pigment, which causes skin coloring, is produced in the melanin-producing granules (melanosomes) in the melanocytes (melanocytes) between the epidermis and the dermis, and the produced melanin diffuses into adjacent cells by osmotic action. . The biochemical reaction in this melanocyte is presumed to be as follows. That is, tyrosine, which is an essential amino acid, is converted into dopaquinone by the action of the enzyme tyrosinase, and the process in which it is converted to black melanin via a red pigment and a colorless pigment by an enzymatic or non-enzymatic oxidative action is a melanin pigment production process. Therefore, suppressing the action of tyrosinase, which is the first step of the reaction, is important for suppressing melanin production.

However, except for hydroquinone, the compounds that suppress the action of tyrosinase have extremely slow onset of their effects, and therefore the effect of improving skin pigmentation is not sufficient. On the other hand, although hydroquinone is recognized as having an effect, its use is generally restricted because of its sensitizing properties. In order to improve the safety, attempts have been made to use monoesters or alkyl monoethers of higher fatty acids (Japanese Patent Application Laid-Open No. 58-154507), but the esters are decomposed by hydrolytic enzymes in the body. For this reason, it is not always safe to say, and ethers have not been obtained that are sufficiently satisfactory in terms of safety.

On the other hand, in recent years, it has been revealed that proteases are involved in the pathological formation of various skin diseases. For example, in psoriasis, which is a representative of inflammatory dyskeratosis, high plasminogen activator (PA) activity is observed in the affected epidermis. While PA is one of the serine proteases, Haustein reports that strong PA activity is present in psoriatic epidermis, especially at the site of parakeratosis (Arch. Klin. Exp.
Dermatol; 234, 1969), Fraki and Hopsu-Ha
vu extracted PA activity from psoriatic scales using a high concentration salt solution (Arch. Dermatol. Res; 256,1976). Also,
In pemphigus vulgaris, a large amount of PA synthesized in epidermal cells is converted into extracellular plasminogen (Plasmini).
gen) to plasmin, which digests intercellular binders to store interstitial fluid between cells and form blisters in the epidermis.
itro) in experimental systems (Morioka
S. et al: J. Invest. Dermatol; 76,1981). Proteases are also considered to play an important role in the normal keratinization process of the epidermis such as stratum corneum formation (Ogaw
a H., Yoshiike T .: Int. J. Dermatol; 23, 1984), and attempts have been made to use protease inhibitors as agents for improving skin or treating skin diseases.

[0005]

In view of the above situation, the present inventors have investigated a melanin production inhibitory effect and a protease inhibitory activity for a wide variety of substances, and as a result, Yawar Piri-pyri (Yawar Piri- Pi
It was found that an extract of ri, scientific name: Eleucerine plicata) has a melanin production inhibitory action and a protease inhibitory action, and completed the present invention. Yawah
There has been no report on the melanin production-inhibitory effect of an extract of Yawar Piri-Piri, and its application to a whitening agent or a protease inhibitor has not been known at all. Also, Yawar Piri Piri (Yawar
There is no example of incorporating an extract of Piri-Piri) into an external preparation for skin. The present inventors have completed the present invention based on the above findings.

That is, the present invention relates to Yawar Piri-Piri (scientific name: Eleucerine).
plicata) is an external preparation for the skin, which is characterized by containing an extract.

Hereinafter, the configuration of the present invention will be described in detail. Yawar P for use in the present invention (Yawar P
iri-Piri) is a plant that grows in South America, especially in dry grasslands such as the Andes, grasses and the like. The extract used in the present invention includes leaves, stems, fruits, etc.
It is obtained by immersing or heating and refluxing the whole plant of Pili-Piri, followed by filtration and concentration. The extraction solvent used in the present invention may be any solvent that is generally used for extraction, and in particular, alcohols such as methanol and ethanol,
Organic solvents such as hydrous alcohols, acetone and ethyl acetate can be used alone or in combination.

In the present invention, Yawa-Pi-Pi-Pi (Ya
The amount of the war Piri-Piri) extract compounded is 0.005 to 20.0% by weight, preferably 0.01 to 10.0% by weight, as a dried product in the total amount of the external preparation. 0.
If it is less than 005% by weight, the effect of the present invention is not sufficiently exhibited, and if it exceeds 20.0% by weight, formulation is difficult, which is not preferable. Further, even if the content is 10.0% by weight or more, the effect is not so much improved.

The external preparation for skin of the present invention is preferably applied as a whitening agent or a protease inhibitor. Protease, which is a protease inhibitor, is a general term for enzymes that catalyze the hydrolysis of peptide bonds, and this protease is classified into peptidases and proteinases. The former is an enzyme that cleaves a peptide bond from the outside of the amino group terminal or the carboxyl group terminal of the peptide chain, and the latter is an enzyme that cleaves a specific bond inside the peptide chain. The latter proteinases are further roughly classified into four types, serine, cysteine, aspartic acid, and metal, depending on the type of active catalytic group, and each has a specific inhibitor. The protease inhibitor in the present invention is characterized by exhibiting inhibitory activity against serine protease among them.

The external preparation for skin of the present invention contains, in addition to the above-mentioned essential components, components that are usually used in external preparations for skin such as cosmetics and pharmaceuticals, for example, other whitening agents, moisturizing agents, antioxidants,
An oily component, an ultraviolet absorber, a surfactant, a thickener, an alcohol, a powder component, a coloring material, an aqueous component, water, various skin nutritional agents and the like can be appropriately blended as necessary.

Other metal sequestering agents such as disodium edetate, trisodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate, gluconic acid, caffeine, tannin, verapamil, tranexamic acid and its derivatives, licorice extraction Substance, glabridin, hot water extract of fruits of fire thorns, various crude drugs, tocopherol acetate,
Drugs such as glycyrrhizic acid and its derivatives or salts thereof, vitamin C, magnesium ascorbate phosphate,
Other whitening agents such as ascorbic acid glucoside, arbutin, kojic acid, glucose, fructose, mannose,
Sugars such as sucrose and trehalose can also be appropriately blended.

The external preparation for skin of the present invention may be any ointment, cream, milky lotion, lotion, pack, bath agent or the like as long as it is a conventional external preparation for skin, and its form is not particularly limited.

[0013]

Next, the present invention will be described in more detail by way of examples. Note that the present invention is not limited by this. The compounding amount is% by weight. Prior to the Examples, a test method and results of the melanin suppressing effect, tyrosinase activity inhibiting effect and whitening effect, and protease inhibiting effect of the plant extract of the present invention will be described.

Test methods for melanin inhibitory effect, tyrosinase activity inhibitory effect and whitening effect and their results 1. Sample Preparation Yawar Piri-Pir
50 g of the stem and branch portion of i) was immersed in ethanol at room temperature for 1 week, the extract was concentrated, and the ethanol extract 1.8
g was obtained. This extract was dissolved in DMSO at 1%, the concentration was adjusted by diluting this solution, and the following experiment was performed using this.

2. Cell culture method B16 melanoma cultured cells derived from mice were used. 1
0% FBS and theophylline (0.09 mg / ml)
The cells were cultured in an Eagle MEM medium containing C. in a CO ₂ incubator (95% air, 5% carbon dioxide) at 37 ° C. After 24 hours of culturing, the sample solution was added so as to have a final concentration (concentration of extracted dry matter) of 10 ^-2 to 10 ^-5 % by weight, culturing was continued for another 3 days, and the melanin production amount was visually sensed by the following method. The determination and the tyrosinase activity inhibitory effect were measured.

3. Visual measurement of melanin amount A diffusion plate was placed on the lid of the plate of the well, the intracellular melanin amount was observed with an inverted microscope, and compared with the case of a sample (standard) to which plant extract was not added. The results are shown in Table 1. In addition, as a reference example, the same test as above was carried out on an extract of Kaigai (Lamiaceae, Odorikosou Subfamily), which is already known to have an action of suppressing melanin production. Table 1 also shows the results. Further, in the table, "toxic" means that it is cytotoxic.

<Judgment Criteria> ◯: White (amount of melanin) Δ: Slightly white (amount of melanin) ×: Reference (amount of melanin)

4. Measurement of tyrosinase activity Before measurement, the medium in the wells is removed and washed twice with 100 μl of PBS. 45 μl of 1% Triton-X in each well
(Rohm and Haas product name, surfactant) containing PBS is added. Shake the plate for 1 minute, break the cell membrane well, and use a microplate reader for 475n.
The absorbance at m was measured, and this was taken as the absorbance at 0 minutes. Then, 5 μl of 10 mM L-DOPA solution was quickly added, and the mixture was transferred to an incubator at 37 ° C. and reacted for 60 minutes. The plate was shaken for 1 minute, and the absorbance (475 nm) at 60 minutes was measured. The tyrosinase activity inhibition rate (%) was defined as the decrease in the absorbance difference of the plant extract-added sample with respect to the absorbance difference at 0 minutes and 60 minutes in the case of the sample to which the plant extract was not added (control). Table 1 shows the results. Further, as a reference example, the same test as above was carried out on an ethanol extract of mussel, which is already known to have a tyrosinase activity inhibitory action. Table 1 also shows the results. In the table, "toxic" means that cytotoxicity was observed, and "-" means that no significant difference was observed within a risk rate of 5% as compared with the control.

[0019]

[Table 1] ─────────────────────────────────── Test Melanin production Visual evaluation Tyrosinase activity inhibition rate ( %) ──────── ──────────────────────── concentration (wt%) 10 ^-5 10 ^-4 10 ^-3 10 ^{- 2} 10 ^-5 10 ^-4 10 ^-3 10 ^-2 ─────────────────────────────────── Yawa Pori-Pori extract ○ △ ○ Toxicity − − 72 Toxicity Kaigai Extract × × × × − − − − 55 ─────────────────────────── ─────────

[5] Whitening test [Test method] 40 subjects exposed to sunlight in summer for 4 hours (2 hours per day for 2 days) each sample from 5 days after the day of sun exposure to the skin of the upper arm inner skin Was applied once each morning and evening for 4 weeks. The panel was divided into 8 groups, and 5 groups were prepared, and the tests were conducted according to the formulations shown below. (Alcohol phase) 95% Ethyl alcohol 55.0% by weight Polyoxyethylene (25 mol) hydrogenated castor oil ether 2.0 Antioxidant / preservative proper amount Fragrance proper amount drug (listed in Table 2) (water phase) glycerin 5.0 Sodium hexametaphosphate Suitable amount Ion-exchanged water Residue <Production method> An aqueous phase and an alcohol phase are prepared, respectively, and then both are mixed and solubilized.

[Evaluation Method] The lightening effect after use was judged based on the following judgment criteria. <Judgment criteria> ：: When the ratio showing significant effect and effectiveness among the subjects is 80% or more 割 合: The ratio showing significant effect and effectiveness among the subjects is 50% or more
Less than 80% △: The proportion of the test subjects showing excellent and effective is 30% or more
When less than 50% x: When the ratio of markedly effective or effective among the subjects is less than 30%

Samples having the blending composition described in the above test method were prepared and the whitening effect was compared using the agents shown in Table 2.
The results are shown in Table 2.

[0023]

[Table 2] ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── ──────────────────── Additive- × Hydroquinone 1.0 △ Yawari-Piri-Phi extract 0.1 ○ Yawari-Piri-Piri extract 1.0 ○ Yawari Piri Piri Extract 10.0 ◎ ────────────────────────────

The Yawah Piri-Piri extract shown in Table 2 was obtained from Yawar Piri-Pir.
It is obtained by heating and reducing the whole plant of i) in ethanol, filtering and concentrating and drying.

As is clear from Table 2, the effect after exposure to sunlight is that the addition of the yawa-pyri-pyri extract prevents the deposition of excess melanin pigment and prevents darkening. Was confirmed.

Test Method Regarding Protease Inhibitory Effect and Results The inhibitory activity against plasmin and trypsin was evaluated as two typical serine proteases.

1. Sample Preparation Yawar Piri-Pir
The stem and branch portions of i) were immersed in ethanol for 1 week at room temperature, and the extract was concentrated to dryness. This solid was dissolved again in ethanol to prepare a 1% solution.

2. Measurement of plasmin inhibitory activity The percent inhibition was determined by the fibrin plate method. That is, As
Prepare a fibrin plate according to the method of trup et al. (Arch. B-iochem .; 40,346,1952), and use the sample prepared as above diluted with ethanol to 0.1% and 0.01%. did. The results are shown in Table 3.

3. Measurement of trypsin inhibitory activity Muramatu et al. (J. Bioche
m .; 58, 214, 1965) and the inhibition rate was determined. Samples were also diluted to 0.1% and 0.01%, and the results are shown in Table 3. In addition, as a reference example, Kunyi (Zingiberaceae), which is a plant whose application is already known for rough skin, is
t, scientific name: Curcuma domestica), ginger (Zingibera)
Lempuyang (scientific name: Zi)
ngiber aromaticum Mal.) and the ethanolic extract of mugwort were subjected to the same test as above. Table 3 also shows the results.

[0030]

[Table 3] ────────────────────────────────── Inhibition rate (%) Sample addition concentration ──── ─────────── Plasmin Trypsin ────────────────────────────────── Yawa Piri -Piri 0.1% 36.4 30.8 0.01% 26.7 23.2 Khunit 0.1% 3.0 0 0.01% 0 0 Rempuyang 0.1% 0 0 0.01% 0 0 Artemisia 0.1% 18.6 0 0.01% 5.8 0 ───────────── ─────────────────────

Example 1 Cream (Formulation) Stearic acid 5.0% by weight Stearyl alcohol 4.0 Isopropyl myristate 18.0 Glycerin monostearate 3.0 Propylene glycol 10.0 Yawa Piri-pyrimethanol extract 0 .01 Caustic potassium 0.2 Sodium bisulfite 0.01 Preservative proper amount Perfume proper amount Ion-exchanged water Residual (manufacturing method) Propylene glycol, Yawari-pyrimethanol extract and caustic potash were added to ion-exchanged water to dissolve and heated to 70 Keep at ℃ (water phase). The other components are mixed, melted by heating and kept at 70 ° C. (oil phase). The oil phase is gradually added to the water phase, and after the addition is completed, the temperature is maintained for a while to cause a reaction. Then, it is uniformly emulsified with a homomixer and cooled to 30 ° C. with thorough stirring.

Example 2 Cream (Formulation) Stearic acid 2.0% by weight Stearyl alcohol 7.0 Hydrogenated lanolin 2.0 Squalane 5.0 2-Octyldodecyl alcohol 6.0 Polyoxyethylene (25 mol) cetyl alcohol ether 3.0 Glycerin monostearate 2.0 Propylene glycol 5.0 Yawah Pyri-Pyriethanol extract 0.05 Sodium hydrogen sulfite 0.03 Ethylparaben 0.3 Fragrance suitable amount Ion-exchanged water Residual (production method) Ion-exchanged water Add propylene glycol to
Heat and maintain at 70 ° C. (aqueous phase). The other components are mixed, melted by heating and kept at 70 ° C. (oil phase). The oil phase is added to the aqueous phase to carry out preliminary emulsification, and the mixture is uniformly emulsified with a homomixer and then cooled to 30 ° C. with thorough stirring.

Example 3 Cream (Formulation) Solid paraffin 5.0 wt% Beeswax 10.0 Vaseline 15.0 Liquid paraffin 41.0 Glycerin monostearate 2.0 Polyoxyethylene (20 mol) sorbitan monolaurate 2 0.0 Soap powder 0.1 Borax 0.2 Yawa-pyri-pyriacetone extract 0.05 Yawa-pyri-pyriethanol extract 0.05 Sodium hydrogen sulfite 0.03 Ethylparaben 0.3 Perfume proper amount Ion-exchanged water residue ( Manufacturing method) Soap powder and borax are added to ion-exchanged water, and the mixture is heated and melted and kept at 70 ° C (aqueous phase). The other components are mixed, melted by heating and kept at 70 ° C. (oil phase). The oil phase is gradually added to the aqueous phase while stirring to carry out the reaction. After the reaction is completed, the mixture is uniformly emulsified with a homomixer, and after emulsification, the mixture is cooled to 30 ° C. with thorough stirring.

Example 4 Emulsion (formulation) Stearic acid 2.5 wt% Cetyl alcohol 1.5 Vaseline 5.0 Liquid paraffin 10.0 Polyoxyethylene (10 mol) monooleate 2.0 Polyethylene glycol 1500 3. 0 triethanolamine 1.0 carboxyvinyl polymer 0.05 (trade name: Carbopol 941, BFGoodrich Chemical company) Yawa Pyri-pyriacetic acid ethyl ester extract 0.01 sodium bisulfite 0.01 ethylparaben 0.3 fragrance Appropriate amount Ion-exchanged water Residue (production method) Dissolve carboxyvinyl polymer in a small amount of ion-exchanged water (phase A). Polyethylene glycol 1500 and triethanolamine are added to the remaining ion-exchanged water, dissolved by heating, and kept at 70 ° C. (aqueous phase). The other components are mixed, melted by heating and kept at 70 ° C. (oil phase). The oil phase is added to the water phase to perform preliminary emulsification, the phase A is added, and the mixture is uniformly emulsified with a homomixer. After the emulsification, the mixture is cooled to 30 ° C. while stirring well.

Example 5 Emulsion (Formulation) Microcrystalline wax 1.0% by weight Beeswax 2.0 Lanolin 20.0 Liquid paraffin 10.0 Squalane 5.0 Sorbitan sesquioleate 4.0 Polyoxyethylene (20 moles) ) Sorbitan monooleate 1.0 Propylene glycol 7.0 Yawa Pyri-pyriacetone extract 10.0 Sodium hydrogen sulfite 0.01 Ethylparaben 0.3 Fragrance suitable amount Ion-exchanged water Residual (production method) Propylene glycol in ion-exchanged water And add
Heat and maintain at 70 ° C. (aqueous phase). The other components are mixed, heated and melted and kept at 70 ° C. (oil phase). While stirring the oil phase, the aqueous phase is gradually added thereto, and the mixture is uniformly emulsified with a homomixer. After emulsification, cool to 30 ° C with good stirring.

Example 6 Jelly (formulation) 95% ethyl alcohol 10.0% by weight dipropylene glycol 15.0 polyoxyethylene (50 mol) oleyl alcohol ether 2.0 carboxyvinyl polymer 1.0 (trade name: Carbopol 940, BFGoodrich Chemical company) Caustic soda 0.15 L-Arginine 0.1 Yawah Pyri-Pyri 50% ethanol aqueous solution extract 7.0 2-Hydroxy-4-methoxybenzophenone sodium sulfonate 0.05 Ethylenediaminetetraacetate-3 sodium・ 2 water 0.05 Methylparaben 0.2 Perfume proper amount Ion-exchanged water Residue (production method) Carbopol 940 is uniformly dissolved in ion-exchanged water, while Yawa Piri-Pyri 5 is added to 95% ethanol.
0% aqueous ethanol extract, polyoxyethylene (5
0 mol) oleyl alcohol ether is dissolved and added to the aqueous phase. Next, after adding other components, the mixture is neutralized with caustic soda and L-arginine to increase the viscosity.

Example 7 Beauty Serum (Formulation) (Phase A) Ethyl Alcohol (95%) 10.0% by Weight Polyoxyethylene (20 mol) Octyldodecanol 1.0 Pantotenyl Ethyl Ether 0.1 Yawah Piri Pyrimethanol extract 1.5 Methylparaben 0.15 (Phase B) Potassium hydroxide 0.1 (Phase C) Glycerin 5.0 Dipropylene glycol 10.0 Sodium bisulfite 0.03 Carboxyvinyl polymer 0.2 (trade name) : Carbopol 940, BFGoodrich Chemical company) Purified water Residue (Production method) A phase and C phase are uniformly dissolved, and A phase is added to C phase.
Add phases and solubilize. Next, after adding the phase B, filling is performed.

Example 8 Pack (formulation) (Phase A) 5.0% by weight dipropylene glycol Polyoxyethylene (60 mol) hydrogenated castor oil 5.0 (Phase B) Yawa Piri-pyrimethanol extract 0.01 Olive oil 5.0 Tocopherol acetate 0.2 Ethylparaben 0.2 Perfume 0.2 (Phase C) Sodium bisulfite 0.03 Polyvinyl alcohol 13.0 (Saponification degree 90, degree of polymerization 2,000) Ethanol 7.0 Purification Water Residue (Production method) A phase, B phase, and C phase are uniformly dissolved,
Add phase B to phase and solubilize. Next, this is added to the C phase and then filled.

Example 9 Solid foundation (formulation) Talc 43.1% by weight Kaolin 15.0 Sericite 10.0 Zinc white 7.0 Titanium dioxide 3.8 Yellow iron oxide 2.9 Black iron oxide 0.2 Squalane 8 0.0 Isostearic acid 4.0 POE sorbitan monooleate 3.0 Isocetyl octoate 2.0 Yawa-Pyri-Pyriethanol extract 1.0 Preservative proper amount Perfume appropriate amount (Manufacturing method) Blend talc to black iron oxide powder component Sufficiently mixed with squalane to isocetyl octoate, the yawa-pyri-pyriethanol extract, preservative, and fragrance, and kneaded well, then filled into a container and molded.

Example 10 Emulsion type foundation (cream type) (Prescription) (Powder part) Titanium dioxide 10.3 wt% Sericite 5.4 Kaolin 3.0 Yellow iron oxide 0.8 Bengala 0.3 Black iron oxide 0.2 (Oil phase) Decamethylcyclopentasiloxane 11.5 Liquid paraffin 4.5 Polyoxyethylene-modified dimethylpolysiloxane 4.0 (Aqueous phase) Purified water 50.0 1,3-Butylene glycol 4.5 Yawa -Pyri-pyriethanol extract 1.5 Sorbitan sesquioleate 3.0 Preservative proper amount Perfume proper amount (Production method) After heating and stirring the aqueous phase, the powder portion thoroughly mixed and pulverized is added and treated with a homomixer. Further, the oil phase mixed by heating is added, and the mixture is treated with a homomixer. Then, a fragrance is added with stirring, and the mixture is cooled to room temperature.

[0041]

Industrial Applicability As described above, the external preparation for skin of the present invention has a melanin production inhibitory action and a tyrosinase activity inhibitory action, and it causes lightening of pigmentation, stains, freckles, melasma etc. after sunburn. In addition to having excellent whitening effects, it also has an excellent protease inhibitory effect, and is effective for various skin diseases,
It is expected to have an excellent effect in improving rough skin and rough skin.

─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. ⁶ Identification code Internal reference number FI Technical indication location A61K 35/78 ADS A61K 35/78 ADS AED AEDC C12N 9/99 C12N 9/99 (72) Inventor Yuzo Yoshida 1050 Shinba-cho, Kohoku-ku, Yokohama-shi, Kanagawa Inside Shiseido Daiichi Research Center, Inc.

Claims (4)

[Claims] 1. Yawar Pi
ri-Piri, scientific name: Eleucerine plicata), an external preparation for skin characterized by being compounded. 2. The external preparation for skin according to claim 1, which is a whitening agent. 3. The external preparation for skin according to claim 1, which is a protease inhibitor. 4. The external preparation for skin according to any one of claims 1 to 3, wherein the compounded amount of the extract of Yawa-Pili-Pyri is 0.005 to 20.0% by weight.